SCHEMBL5566880

SCHEMBL5566880

COc1cc2c(Nc3cc(-c4ccc(Cl)c(Cl)c4)[nH]n3)ncnc2cc1OCC1CCN(C)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 10/20 0.65
▸ SRC P12931 3/20 0.65
▸ EGFR P00533 14/20 0.62
▸ EPHA2 P29317 5/20 0.61
▸ EPHB4 P54760 5/20 0.61
▸ ERBB2 P04626 2/20 0.61
▸ FLT1 P17948 5/20 0.60
▸ FGFR1 P11362 4/20 0.60
▸ FLT4 P35916 4/20 0.60
▸ CSK P41240 2/20 0.60
▸ TEK Q02763 2/20 0.60
▸ BMPR1B O00238 1/20 0.56
▸ PLK4 O00444 1/20 0.56
▸ CIT O14578 1/20 0.56
▸ GAK O14976 1/20 0.56
▸ EPHB6 O15197 1/20 0.56
▸ RIPK2 O43353 1/20 0.56
▸ ROCK2 O75116 1/20 0.56
▸ STK10 O94804 1/20 0.56
▸ MAP4K4 O95819 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5567635 0.92 EGFR (0.68) KDRSRCEGFREPHA2EPHB4
SCHEMBL5565975 0.90 EGFR (0.68) KDRSRCEGFREPHA2EPHB4
SCHEMBL5562091 0.90 KDR (0.65) KDRSRCEGFREPHA2EPHB4
Hydrochloric Acid SCHEMBL5566572 0.89 KDR (0.64) KDRSRCEGFREPHA2EPHB4
SCHEMBL5567690 0.89 EGFR (0.73) KDREGFR
Hydrochloric Acid SCHEMBL6444589 0.88 EGFR (0.72) KDREGFRFLT1FGFR1FLT4
SCHEMBL5566528 0.85 EGFR (0.61) KDRSRCEGFREPHA2EPHB4
SCHEMBL5649175 0.79 KDR (0.79) KDRSRCEGFREPHA2EPHB4
SCHEMBL7882903 0.79 KDR (0.47) KDREGFREPHA2EPHB4ERBB2
Azm-475271 SCHEMBL29388701 0.79 KDR (1.00) KDRSRCEGFREPHA2EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262201-B1 For the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals ASTRAZENECA AB (SE) 2007-08-28 — — US disclosed
Send feedback